GLP-1 receptor agonist use linked to nonarteritic anterior ischemic optic neuropathy

For older adults with type 2 diabetes, glucagon-like peptide-1 receptor agonist (GLP-1 RA) use is associated with nonarteritic anterior ischemic optic neuropathy (NAION), according to a research letter published online July 31 in JAMA Ophthalmology.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup